Neuigkeiten & Ereignisse

Wir laden unsere Kunden und Partner die Updates von ARS-Aktivitäten sowie Nachrichten zu ausgewählten Medikamenten und biologischen Entwicklungen zu verfolgen. Machen Sie gerne einen Termin für ein Meeting mit uns während der Life Science Veranstaltungen, auf denen wir vertreten sind, um potenzielle und aktuelle Projekte persönlich und im Detail zu diskutieren.

New BE projects

ARS signed an agreement for conducting a number of local bioequivalence studies of generics treating diabetes mellitus type II. ARS is responsible for medical writing, regulatory, clinical and analytical parts as well as final CSR preparation.  

Happy Holiday Season!

We wish our Partners and Colleagues health, prosperity, good fortune, and progress in 2019!

Independent audit

The ARS CRO as well its partnering BE Unit and PK lab have been qualified by the external auditor for conducting series of local bioequivalence clinical trials sponsored by the EU pharmaceutical company.

Medical writing

ARS signed an agreement with the Russian pharmaceutical company on medical writing services, namely clinical study essential documents development for six local bioequivalence clinical research projects.

BE project

ARS signed a new agreement with its current Client to conduct a bioequivalence clinical trial for Posaconazole suspension.

DSUR contract

ARS signed the agreement to prepare the drug safety update report (DSUR) for submitting to the Federal Service for Surveillance in Healthcare (Roszdravnadzor). The report will be developed by the ARS pharmacovigilance team within the current Phase III gynecology clinical research project sponsored by the leading Russian pharmaceutical company.

New registration contract

ARS conducted a contract with the Russian pharmaceutical company developing generic drugs. The agreement includes ARS assistance with the marketing authorization of the three products in Russia.

MA contract

ARS made a contract with the pharmaceutical company focused on orphan medicines. The project covers local marketing authorization of the drug treating thrombocytosis.

White Nights OncoForum

ARS representatives visited the 4th St. Petersburg International Oncology Forum that is the biggest regional conference in the area. There were interesting and informative discussions and presentations devoted to biosimilars development, oncology clinical research in Russia and local legislation issues within the clinical studies round table held on 08-Jul-2018.

International Multicenter Clinical Studies in Russia

The trends and opportunities in the multinational multicenter clinical trials (MMCT) in Russia are reviewed in the recent article.